Kidney TransplantationNCT00209196
Quality of Life in Pediatric Transplant Recipients
An observational study of Kidney Transplantation and Liver Transplantation, run by Emory University at 1 site in United States.
Trial summary
Adherence to medical regimens refers to what degree a patient chooses to follow the advice given by his/her healthcare provider. Good adherence typically involves behaviors such as the patient taking medication as directed and going to scheduled clinic appointments. Read more about this study
- Who is it for?
- Ages 11 to 18 years
- Conditions the study is for
- Kidney Transplantation, Liver Transplantation, Heart Transplantation
- How many people
- 65 participants
- Where
- 1 siteUnited States
- Study dates
- May 2005to Jan 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 11 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Male or female Patients at Children's Healthcare of Atlanta Patients at least 11 years old and living at home for 6 months Solid organ transplant patients between 1.1.1988 and 12.31.2004
Who may be able to join
- Solid organ transplant at Children's Healthcare of Atlanta (CHOA)
- 11-18 years of age
- Lives with the parents in the home
- Signed informed consent
Who cannot join
- Has not lived with parent for at least 6 months
- Medical records are not accessible through the CHOA system
Trial locations and contacts
1 site in 1 country.
United States1 site
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322
About this study
Official title: Health Behaviors and Quality of Life in Pediatric Solid Organ Transplant Recipients
Adherence to medical regimens refers to what degree a patient chooses to follow the advice given by his/her healthcare provider. Good adherence typically involves behaviors such as the patient taking medication as directed and going to scheduled clinic appointments. As many patients often do not follow the advice of doctors as closely as suggested, many researchers have tried to find out the reasons behind patients being "non-adherent." This research has looked at medical conditions such as diabetes, cystic fibrosis, and asthma. More recently, researchers have started to look at adherence with children who have undergone solid organ transplantation. This is because about 50% of these children are to some degree non-adherent with their medical regimen. This comes at a costly price as ongoing non-adherence in pediatric transplant can lead to the child's body rejecting the new organ and even death. This study has been designed to look at the reasons that pediatric patients may choose to be non-adherent. This study will look at issues related to the patient (e.g., age, family support), related to the disease and regimen (e.g., length of illness, how complicated the regimen is), related to the medication (e.g., taste, side effects), related to their mind (e.g., memory problems, confusion), and related to their emotions (e.g., being depressed, anxious). The investigators will be looking at each regimen-related behavior, such as attending clinic appointments and will be asking each family about any barriers that make it difficult. The investigators hope that knowing these barriers will help them make interventions that fit the specific issues that each patient faces. Ultimately, doctors, transplant coordinators, and psychological professionals will be able to use this information to intervene early with families who report barriers that impact adherence.
Read the detailed description
This study will involve approximately 100 parents of pediatric patients who have received a solid organ transplant at Children's Healthcare of Atlanta (CHOA) between January 1st, 1988 and December 31st, 2004. Within this sample, pediatric patients who are 11-18 years of age will be invited to participate in a separate component of the project, involving approximately 50 adolescents.
ELIGIBILITY CRITERIA:
For a parent to participate in this study the child must have had a solid organ transplant at CHOA, patient is 5-18 years of age, patient lives with the parent(s) in the home, and informed consent can be obtained. For a child to participate in this study, the child must have had a solid organ transplant at CHOA, patient is 11-18 years of age, patient lives with the parent(s) in the home, and informed assent can be obtained. Family exclusionary criteria are as follows:
- patient has not lived with parent for at least 6 months
- patient's medical records are not accessible through the CHOA system.
All participants will be referred by the respective transplant coordinator or one of the physicians in this study. Parents will be provided with the findings upon request and referrals for psychological services will be made as necessary.
RECRUITMENT:
To recruit participants for the proposed study, children and adolescents who received a solid organ transplant at CHOA between January 1st, 1988 and December 31st, 2004 will be identified by the transplant coordinators or physician for each solid organ. Although multiple methods of recruitment will be used, each family will only be contacted once.
Clinic recruitment with the investigator present:
Any patient family who is scheduled for an upcoming clinic visit will be approached by the transplant coordinator or other clinic-affiliated individual. The investigation will be briefly described and interest in participating will be solicited.
The parent will sign a letter of interest stating either:
- They are interested in learning more. The form will also ask them to provide contact information (home address and telephone number) or
- They are not interested and do not want to be contacted further.
Only letters indicating interest will be given to investigators. If a family signs the letter indicating interest, an investigator present at clinic will approach the family to describe the investigation and obtain consent/assent. The family will have the option to:
- conduct the interview during the present clinic visit,
- schedule a future time to conduct the interview at the clinic, or
- conduct the interview via telephone.
Clinic recruitment with the investigator not present:
If an investigator is not present at the clinic, the transplant coordinator or other clinic-affiliated individual will give the letters indicating interest to an investigator to contact the family via telephone to describe the study. If after the telephone conversation, a parent is interested in participating, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
Mail recruitment:
Any patient family who is not scheduled for an upcoming clinic visit will be contacted via mail from the transplant coordinator and transplant physician. The letter will briefly describe the investigation and a letter of interest will be included. Included will be a postage-paid envelope to return directly to the transplant team. The transplant coordinator or other clinic-affiliated individual will give the letters indicating interest to an investigator to contact the family via telephone to describe the study. If after the telephone conversation, a parent would like to participate, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy to the investigator. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
Telephone recruitment:
If a parent is not seen in the clinic and does not return a letter of interest, the transplant coordinator or other clinic affiliated individual will call the family to briefly describe the investigation and obtain verbal consent for an investigator to contact them via telephone. If they indicate that they are not interested in participating, they will not be contacted further. If a parent verbally consents to being contacted to learn more about the study, an investigator will contact the family via telephone. If after the telephone conversation, a parent would like to participate, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy to the investigator. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
If the family is called three times with no success in reaching them, this will be considered passive refusal and will not be contacted further.
INTERVIEW PROCEDURE:
The interview with each parent will consist of verbal consent and verbal administration of the PEDS-TX Survey, Parent Version 1.0, the Medical Adherence Measure (MAM), the Child Health Questionnaire-Parent Form 50 (CHQ-PF50), the SF-12 Health Survey (SF-12), the Family Relationship Index (FRI), and demographic questions. The interview with each participating adolescent patient will consist of verbal assent and the PEDS-TX Survey, Adolescent Version 1.0, the Medical Adherence Measure (MAM), the Child Health Questionnaire-Child Form 80 (CHQ-CF80), the Adolescent Risk Taking Survey (ARTS), and the Family Relationship Index (FRI). Each interview will be conducted by research assistants and/or graduate students in psychology. They will be trained in all research procedures by the principal investigator. Training will include observed practice of procedures and skills taught, focused on building rapport with and being sensitive to parents and patients with solid organ transplants, verbally administering the assessment questionnaires in an accurate and comfortable manner, giving answers to questions from parents and patients in an instructive manner that do not bias the research, and lastly, being culturally and socioeconomically sensitive when greeting and interviewing families.
The data for this study will likely be obtained over a 6-9 month period, with data from a specific parent and adolescent patient pair occurring within less than a week period (ideally during the same phone call). Each interview will last approximately 45-75 minutes.
MEASURES:
The measures for this investigation are as follows:
- Clinician Derived Measures
- Medical Record Review
- Prescription Refill records
- Self-Report Measures
- Demographic Information
- PEDS-TX Survey, Parent and Adolescent Version 1.0
- Medical Adherence Measure
- Child Health Questionnaire-Parent Form 50
- SF-12 Health Survey
- Family Relationship Index
- Child Health Questionnaire-Child Form 80
- Adolescent Risk Taking Survey.
- Conditions
- Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Heart-Lung Transplantation
- Keywords
- pediatric, transplantation, psychosocial, kidney transplant recipient, liver transplant recipient, heart transplant recipient, lung transplant recipient, heart-lung transplant recipient
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| pediatric solid organ transplants | Adherence to medical regimens refers to what degree a patient chooses to follow the advice given by his/her healthcare provider.More recently, researchers have started to look at adherence with children who have undergone solid organ transplantation. This is because about 50% of these children are to some degree non-adherent with their medical regimen. This comes at a costly price as ongoing non-adherence in pediatric transplant can lead to the child's body rejecting the new organ and even death. This study has been designed to look at the reasons that pediatric patients may choose to be non-adherent. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pediatric Quality of Life Measure (Peds QL)
paper questionaire
Measured: up to one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2005 (estimated)
- Study startMay 2005
- Primary completionJul 2007
- Study completionJan 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Kidney TransplantationStudies of the same condition, open and under way.
- More trials run by Emory UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 65 participants (actual)
Sponsor and investigators
- Lead sponsor
- Emory University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Laura L. Mee, Emory University
- Investigators
- Laura Mee, PhD, Principal investigator, Children's Healthcare of Atlanta
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00209196
- Sponsor's protocol ID
- IRB00045836
- Status last verified
- Feb 2015
- First submitted
- 14 Sep 2005
- Last updated
- 11 Feb 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Feb 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Behaviors and Quality of Life in Pediatric Solid Organ Transplant Recipients
- ClinicalTrials.gov ID
- NCT00209196
- Acronym / sponsor ID
- IRB00045836
- Conditions
- Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Heart-Lung Transplantation
- Keywords
- pediatric, transplantation, psychosocial, kidney transplant recipient, liver transplant recipient, heart transplant recipient, lung transplant recipient, heart-lung transplant recipient
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 65 participants (actual)
- Lead sponsor
- Emory UniversityUniversity, hospital or other
- Study start
- May 2005
- Primary completion
- Jul 2007 (actual)
- Study completion
- Jan 2015 (actual)
- First posted
- 21 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Adherence to medical regimens refers to what degree a patient chooses to follow the advice given by his/her healthcare provider. Good adherence typically involves behaviors such as the patient taking medication as directed and going to scheduled clinic appointments. As many patients often do not follow the advice of doctors as closely as suggested, many researchers have tried to find out the reasons behind patients being "non-adherent." This research has looked at medical conditions such as diabetes, cystic fibrosis, and asthma. More recently, researchers have started to look at adherence with children who have undergone solid organ transplantation. This is because about 50% of these children are to some degree non-adherent with their medical regimen. This comes at a costly price as ongoing non-adherence in pediatric transplant can lead to the child's body rejecting the new organ and even death. This study has been designed to look at the reasons that pediatric patients may choose to be non-adherent. This study will look at issues related to the patient (e.g., age, family support), related to the disease and regimen (e.g., length of illness, how complicated the regimen is), related to the medication (e.g., taste, side effects), related to their mind (e.g., memory problems, confusion), and related to their emotions (e.g., being depressed, anxious). The investigators will be looking at each regimen-related behavior, such as attending clinic appointments and will be asking each family about any barriers that make it difficult. The investigators hope that knowing these barriers will help them make interventions that fit the specific issues that each patient faces. Ultimately, doctors, transplant coordinators, and psychological professionals will be able to use this information to intervene early with families who report barriers that impact adherence.
Detailed description
This study will involve approximately 100 parents of pediatric patients who have received a solid organ transplant at Children's Healthcare of Atlanta (CHOA) between January 1st, 1988 and December 31st, 2004. Within this sample, pediatric patients who are 11-18 years of age will be invited to participate in a separate component of the project, involving approximately 50 adolescents.
ELIGIBILITY CRITERIA:
For a parent to participate in this study the child must have had a solid organ transplant at CHOA, patient is 5-18 years of age, patient lives with the parent(s) in the home, and informed consent can be obtained. For a child to participate in this study, the child must have had a solid organ transplant at CHOA, patient is 11-18 years of age, patient lives with the parent(s) in the home, and informed assent can be obtained. Family exclusionary criteria are as follows:
- patient has not lived with parent for at least 6 months
- patient's medical records are not accessible through the CHOA system.
All participants will be referred by the respective transplant coordinator or one of the physicians in this study. Parents will be provided with the findings upon request and referrals for psychological services will be made as necessary.
RECRUITMENT:
To recruit participants for the proposed study, children and adolescents who received a solid organ transplant at CHOA between January 1st, 1988 and December 31st, 2004 will be identified by the transplant coordinators or physician for each solid organ. Although multiple methods of recruitment will be used, each family will only be contacted once.
Clinic recruitment with the investigator present:
Any patient family who is scheduled for an upcoming clinic visit will be approached by the transplant coordinator or other clinic-affiliated individual. The investigation will be briefly described and interest in participating will be solicited.
The parent will sign a letter of interest stating either:
- They are interested in learning more. The form will also ask them to provide contact information (home address and telephone number) or
- They are not interested and do not want to be contacted further.
Only letters indicating interest will be given to investigators. If a family signs the letter indicating interest, an investigator present at clinic will approach the family to describe the investigation and obtain consent/assent. The family will have the option to:
- conduct the interview during the present clinic visit,
- schedule a future time to conduct the interview at the clinic, or
- conduct the interview via telephone.
Clinic recruitment with the investigator not present:
If an investigator is not present at the clinic, the transplant coordinator or other clinic-affiliated individual will give the letters indicating interest to an investigator to contact the family via telephone to describe the study. If after the telephone conversation, a parent is interested in participating, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
Mail recruitment:
Any patient family who is not scheduled for an upcoming clinic visit will be contacted via mail from the transplant coordinator and transplant physician. The letter will briefly describe the investigation and a letter of interest will be included. Included will be a postage-paid envelope to return directly to the transplant team. The transplant coordinator or other clinic-affiliated individual will give the letters indicating interest to an investigator to contact the family via telephone to describe the study. If after the telephone conversation, a parent would like to participate, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy to the investigator. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
Telephone recruitment:
If a parent is not seen in the clinic and does not return a letter of interest, the transplant coordinator or other clinic affiliated individual will call the family to briefly describe the investigation and obtain verbal consent for an investigator to contact them via telephone. If they indicate that they are not interested in participating, they will not be contacted further. If a parent verbally consents to being contacted to learn more about the study, an investigator will contact the family via telephone. If after the telephone conversation, a parent would like to participate, 2 copies of the consent form will be sent to the parent's home with a self-addressed envelope to return one signed copy to the investigator. Following receipt of this form, the parent will be contacted to schedule either:
- an interview at the clinic or
- an interview via telephone.
If the family is called three times with no success in reaching them, this will be considered passive refusal and will not be contacted further.
INTERVIEW PROCEDURE:
The interview with each parent will consist of verbal consent and verbal administration of the PEDS-TX Survey, Parent Version 1.0, the Medical Adherence Measure (MAM), the Child Health Questionnaire-Parent Form 50 (CHQ-PF50), the SF-12 Health Survey (SF-12), the Family Relationship Index (FRI), and demographic questions. The interview with each participating adolescent patient will consist of verbal assent and the PEDS-TX Survey, Adolescent Version 1.0, the Medical Adherence Measure (MAM), the Child Health Questionnaire-Child Form 80 (CHQ-CF80), the Adolescent Risk Taking Survey (ARTS), and the Family Relationship Index (FRI). Each interview will be conducted by research assistants and/or graduate students in psychology. They will be trained in all research procedures by the principal investigator. Training will include observed practice of procedures and skills taught, focused on building rapport with and being sensitive to parents and patients with solid organ transplants, verbally administering the assessment questionnaires in an accurate and comfortable manner, giving answers to questions from parents and patients in an instructive manner that do not bias the research, and lastly, being culturally and socioeconomically sensitive when greeting and interviewing families.
The data for this study will likely be obtained over a 6-9 month period, with data from a specific parent and adolescent patient pair occurring within less than a week period (ideally during the same phone call). Each interview will last approximately 45-75 minutes.
MEASURES:
The measures for this investigation are as follows:
- Clinician Derived Measures
- Medical Record Review
- Prescription Refill records
- Self-Report Measures
- Demographic Information
- PEDS-TX Survey, Parent and Adolescent Version 1.0
- Medical Adherence Measure
- Child Health Questionnaire-Parent Form 50
- SF-12 Health Survey
- Family Relationship Index
- Child Health Questionnaire-Child Form 80
- Adolescent Risk Taking Survey.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| pediatric solid organ transplants | – | –Adherence to medical regimens refers to what degree a patient chooses to follow the advice given by his/her healthcare provider.More recently, researchers have started to look at adherence with children who have undergone solid organ transplantation. This is because about 50% of these children are to some degree non-adherent with their medical regimen. This comes at a costly price as ongoing non-adherence in pediatric transplant can lead to the child's body rejecting the new organ and even death. This study has been designed to look at the reasons that pediatric patients may choose to be non-adherent. |
Who may qualify
- Ages
- 11 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Male or female Patients at Children's Healthcare of Atlanta Patients at least 11 years old and living at home for 6 months Solid organ transplant patients between 1.1.1988 and 12.31.2004
Key inclusion criteria (4 listed)
- Solid organ transplant at Children's Healthcare of Atlanta (CHOA)
- 11-18 years of age
- Lives with the parents in the home
- Signed informed consent
Key exclusion criteria (2 listed)
- Has not lived with parent for at least 6 months
- Medical records are not accessible through the CHOA system
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Pediatric Quality of Life Measure (Peds QL)
Time frame: up to one year
paper questionaire
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Feb 2015.
Related trials for Kidney Transplantation
Not yet recruitingPhase 2
(TNX-1500) in Kidney Transplant Recipients
Kidney Transplant, Kidney Transplant Failure and Rejection
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruitingObservational study
Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection
Renal Transplantation; Complication, Renal Transplant
RecruitingObservational study
Il Registro Italiano di Dialisi Pediatrica (RIDP) - Italian Registry of Pediatric Dialysis
Dialysis, Kidney Transplantation
Not yet recruitingPhase 3
A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients
C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent Glomerular Disease After Kidney Transplantation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Laura Mee, PhD principal investigator
Children's Healthcare of Atlanta
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Kidney Transplantation and Liver Transplantation, run by Emory University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Feb 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pediatric Quality of Life Measure (Peds QL) (time frame: up to one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2015.